Literature DB >> 12873665

Prostate localization using transabdominal ultrasound imaging.

Frieda Trichter1, Ronald D Ennis.   

Abstract

PURPOSE: Adding margin around a target is done in an attempt to ensure complete coverage of the target. The B-mode acquisition and targeting (BAT) system allows ultrasound imaging of the prostate in patients with a full bladder. This provides a setup tool for patients with localized prostate cancer that takes into account real-time prostate position and may make it possible to decrease tumor margins. Prostate localization using the conventional setup verification method and daily isocenter shifts recommended by the ultrasound imaging system (BAT) were compared and analyzed. METHODS AND MATERIALS: Daily treatment isocenter shifts for patients with localized adenocarcinoma of the prostate, obtained from two different imaging modalities, electronic portal imaging (EPI) and BAT, were calculated. We studied the difference in patient setup error calculated using BAT contour alignment and measured from EPI; the reproducibility of BAT contour alignment; intrafraction prostate motion; and how the BAT imaging procedure itself affected the prostate position. Prostate motion relative to its position during simulation was calculated by subtracting the EPI-measured isocenter shifts from the corresponding BAT-defined isocenter shifts. BAT reproducibility was measured by taking a verification BAT image after the patient was moved according to the initial BAT-defined isocenter shifts. Intrafraction prostate motion was measured by repeating BAT imaging at the end of a treatment fraction. The BAT imaging effect on prostate position was studied by examining the effect of suprapubic pressure on seed position in patients after a seed implant.
RESULTS: The mean BAT isocenter shifts for prostate motion were 0.32 +/- 0.46 cm in the lateral, 0.31 +/- 0.73 cm in the superoinferior, and 0.32 +/- 0.56 cm in the AP directions. Isocenter shifts obtained from EPI measurements were significantly smaller, with a mean of 0.05 +/- 0.24 cm in the lateral, 0.01 +/- 0.11 cm in the superoinferior and -0.11 +/- 0.29 cm in the AP directions. This larger shift seen by BAT was due to prostate motion. For BAT reproducibility, the results showed that for BAT verification images, 90% of the lateral shifts were <0.2 cm, 93% of the superoinferior shifts were <0.3 cm, and 83% of the AP shifts were <0.2 cm. The mean isocenter shift (intrafraction localization error) during patient treatment fraction was 0.02 +/- 0.28 cm in the lateral, 0.04 +/- 0.48 cm in the superoinferior, and 0.0 +/- 0.32 cm in the AP direction. The BAT procedure itself induced an average motion of 1 mm in the AP and superoinferior directions.
CONCLUSIONS: Prostate patient setup verification on the basis of bony anatomy position does not reflect the actual prostate position. BAT ultrasound target alignment provides a real-time prostate localization system that may make it possible to measure prostate position variations and reduce margins.

Entities:  

Mesh:

Year:  2003        PMID: 12873665     DOI: 10.1016/s0360-3016(03)00269-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.

Authors:  Su Yu Zhu; Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

2.  Changes in rectal volume and prostate localization due to placement of a rectum-emptying tube.

Authors:  Hiroshi Fuji; Shigeyuki Murayama; Masashi Niwakawa; Raizou Yamaguchi; Ryou Yamashita; Takashi Matsui; Haruo Yamashita; Tetsuo Nishimura; Kenichi Tobisu
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

3.  A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy.

Authors:  Jinkoo Kim; Sanath Kumar; Chang Liu; Hualiang Zhong; Deepak Pradhan; Mira Shah; Richard Cattaneo; Raphael Yechieli; Jared R Robbins; Mohamed A Elshaikh; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2013-10-31       Impact factor: 3.609

4.  Impact of robotic ultrasound image guidance on plan quality in SBRT of the prostate.

Authors:  Stefan Gerlach; Ivo Kuhlemann; Floris Ernst; Christoph Fürweger; Alexander Schlaefer
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

5.  A survey of image-guided radiation therapy use in the United States.

Authors:  Daniel R Simpson; Joshua D Lawson; Sameer K Nath; Brent S Rose; Arno J Mundt; Loren K Mell
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Authors:  Markus Bohrer; Peter Schröder; Grit Welzel; Hansjörg Wertz; Frank Lohr; Frederik Wenz; Sabine Kathrin Mai
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

7.  An error analysis perspective for patient alignment systems.

Authors:  Michael Figl; Marcus Kaar; Rainer Hoffman; Alfred Kratochwil; Johann Hummel
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-03-06       Impact factor: 2.924

Review 8.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

9.  A comparison of radiographic techniques and electromagnetic transponders for localization of the prostate.

Authors:  Ryan D Foster; David A Pistenmaa; Timothy D Solberg
Journal:  Radiat Oncol       Date:  2012-06-21       Impact factor: 3.481

10.  Tomotherapy as a tool in image-guided radiation therapy (IGRT): theoretical and technological aspects.

Authors:  S Yartsev; T Kron; J Van Dyk
Journal:  Biomed Imaging Interv J       Date:  2007-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.